Recombinant Human PYY Protein，His

Peptide YY (PYY) is a gastrointestinal hormone primarily secreted by the L-cells in the intestines in response to food intake. It plays a crucial role in regulating appetite, food intake, and energy balance by inhibiting gastric motility and promoting a feeling of fullness. Due to its physiological significance, the recombinant production of PYY has garnered interest in both basic research and therapeutic applications. The molecular understanding of PYY's structure and function has opened avenues for exploring its potential in treating obesity and metabolic disorders. Researchers have focused on developing recombinant PYY to study its biological effects more comprehensively and to design analogs that might enhance its effectiveness as a weight-loss drug. By utilizing advanced genetic engineering and protein expression techniques, scientists aim to generate biologically active forms of PYY that can be used in preclinical and clinical studies. Additionally, understanding the mechanisms of PYY signaling could lead to novel strategies for modulating appetite and energy expenditure, offering potential benefits for individuals struggling with weight management. Moreover, recombinant PYY could serve as a valuable tool for dissecting the complex interplay between gut hormones and brain signals related to hunger and satiety, thereby enhancing our knowledge of the intricate regulatory networks governing body weight. As obesity rates continue to rise globally, the exploration of PYY and its recombinant forms remains a critical area of research with promising implications for developing effective interventions in metabolic health.